The Impella RP device was approved by the FDA for use as a temporary percutaneous assist for the right ventricle, as announced by Abiomed. Use is approved for up to 14 days for a variety of indications including post MI, heart transplant, open heart surgery, or right heart failure after LVAD implant.
You are here:
First Percutaneous Pump Approved for Right Heart Failure
Submitted by: Mark Ferguson
Source: MedPage Today
Keywords:
Author(s): Crystal Phend
